Under the OPA function, the CWBYCTP charged the contractor for the OPA contract with the following responsibilities:
Monitoring the performance of the CWBYCTP against specific standards is key to helping more patients have a successful bone marrow or umbilical cord blood transplant.
Performance standards for the OPA include:
The OPA contractor regularly reports performance measurements to HRSA.
Learn how the CWBYCTP helps more patients have a successful bone marrow or umbilical cord blood transplant. The CWBYCTP is authorized by the Stem Cell Therapeutic and Research Act of 2005, Public Law 109-129, as amended by P.L. 111-264 and reauthorized in P.L. 114-104.
A bone marrow or cord blood transplant replaces a patient's diseased cells with healthy blood-forming cells. These cells can come from the marrow of a donor or the umbilical cord blood that is collected after a baby is born.
Learn more about: